Pregled bibliografske jedinice broj: 957498
Patients' attitude towards reporting suspected adverse drug reactions
Patients' attitude towards reporting suspected adverse drug reactions // FIP Congress on Pharmacy and Pharmaceutical Sciences 2018
Glasgow, Ujedinjeno Kraljevstvo: International Pharmaceutical Federation (FIP), 2018. 0001, 1 (poster, međunarodna recenzija, sažetak, ostalo)
CROSBI ID: 957498 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Patients' attitude towards reporting suspected adverse drug reactions
Autori
Glibo, Ana ; Kosier, Ivana ; Sertić, Miranda
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, ostalo
Izvornik
FIP Congress on Pharmacy and Pharmaceutical Sciences 2018
/ - : International Pharmaceutical Federation (FIP), 2018
Skup
78th FIP World Congress of Pharmacy and Pharmaceutical Sciences
Mjesto i datum
Glasgow, Ujedinjeno Kraljevstvo, 02.09.2018. - 06.09.2018
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
Patients, pharmacists, adverse drug reactions
Sažetak
BackgroundAdverse drug reaction (ADR) is every response to a medicinal product which is noxious and unintended. Primary health care providers play a key role in gathering safety information once a medicine is on the market.MethodsA total of 400 questionnaires, obtained in 46 community pharmacies from 25 urban and rural areas in Croatia, were analyzed. After completing the questionnaire, patients received an educational leaflet, created in collaboration with national pharmacovigilance experts, providing information why and how to report an adverse drug reaction and what information they should include.ResultsThe median age of examined patients was 56 years (range 18-91). Research has shown that a vast majority considers ADR reporting important (98.5%). However, only 50.0% think that every ADR should be reported. 29.4% of those who have experienced an ADR have never reported it. Although most of them consider normal or would like to be asked about their therapy and ADRs by a pharmacist, 14.1% stated that they would not like a pharmacist to ask them about ADRs related to their therapy. Even though community pharmacists are the most accessible health professional, only 17.7% would speak to their pharmacists about ADRs they have experienced first.ConclusionResults obtained in this research indicate the importance of further patient counseling about the process of reporting ADRs. Raising awareness and promoting pharmacists&rsquo ; role as the key part of the health care system is essential.
Izvorni jezik
Engleski
Znanstvena područja
Javno zdravstvo i zdravstvena zaštita, Farmacija